Mutations in BRCA1 and BRCA2 genes increase the risk of breast cancer but may also cause prostate and pancreatic…

Scientists studying the cell replication process have discovered that damage to DNA during the early stages could potentially create…

Scientists at the Sloan Kettering Institute have engineered a new range of immunotherapies that target not only cancer cells…

USCF researchers have developed a new way of looking at cancer immunotherapies, matching the immune environment around the tumour…

Scientists worldwide are doing incredible things to improve the diagnosis and treatment of all forms of cancer. New approaches…

Liquid biopsy tests before and during chemotherapy can accurately detect whether patients with prostate cancer are resistant to treatment…

Scientists have developed a new oral DPP inhibitor that, when used in combination with targeted immunotherapy, has shown promise…

We are delighted to announce the launch of a brand-new branch office dedicated to serving the needs of RGCC…

Chemotherapy drugs could enhance the spread of cancer beyond a primary tumour site, scientists have established. In tests, researchers…

Mutations in cancer-suppressing genes that block cell growth may explain why some cancers evade the body’s immune system, scientists…

Scientists have identified a new synthetic molecular code that could improve a patient’s response to an effective cancer treatment,…

RGCC Network doctors from across the world set their alarm clocks and tuned in for RGCC’s first ever virtual…